Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Ondine Biomedical Inc
OBIOndine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its product platform is Photodisinfection, a light-based antimicrobial technology that provides destruction of pathogens without causing antibiotic resistance. The company's lead product is Steriwave, a nasal photodisinfection solutions that destroys bacteria, viruses, and fungi colonizing the nose which leads to healthcare-associated infections. Its product pipeline also includes the development of topical antiviral therapy for the upper respiratory tract to reduce SARS-CoV-2 titre and transmission; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada. Address: 1100 Melville Street, Vancouver, BC, Canada, V6E 4A6
Analytics
Precio Objetivo de WallStreet
4 915.01 GBXRelación P/E
–Rentabilidad por dividendo
–Cifras clave OBI
- Margen de Beneficio
- Ingresos Totales
- Beneficio Bruto
Análisis de dividendos OBI
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y>5 - expected 5-9 dividend yield on cost over 10Y<5 - expected <5 dividend yield on cost over 10YMaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–Aumento del dividendo durante 5 años
–Crecimiento continuo
–Ratio de pago medio en 5 años
–Tendencia del payout OBI
- Relación de Pago
- Dividends
- Rentabilidad por dividendo
Valoración de la acción OBI
- Relación Precio/Ventas
- Relación PE
- Relación Precio/Valor en Libros
Finanzas OBI
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |